Life after a heart attack
https://libcat.nshealth.ca/en/permalink/chpams34348
Nova Scotia Health Authority. Heart Health Portfolio.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 0016
- Available Online
- View Pamphlet
This pamphlet answers questions you may have after having a heart attack. Lowering your risk factors for heart disease, heart healthy eating, coping with stress, activity, exercises, checking your heart rate, warning signs you are doing too much, medications and how to use nitro spray are covered. Directions for managing chest pain or discomfort at home are given.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Heart Health Portfolio
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (37 p.) : digital, PDF file
- Subjects (MeSH)
- Myocardial Infarction - prevention & control
- Myocardial infarction - rehabilitation
- Heart Diseases - prevention & control
- Subjects (LCSH)
- Myocardial infarction
- Heart--Diseases--Patients--Rehabilitation
- Specialty
- Cardiovascular system
- Abstract
- This pamphlet answers questions you may have after having a heart attack. Lowering your risk factors for heart disease, heart healthy eating, coping with stress, activity, exercises, checking your heart rate, warning signs you are doing too much, medications and how to use nitro spray are covered. Directions for managing chest pain or discomfort at home are given.
- Responsibility
- Prepared by: Heart Health Portfolio
- Pamphlet Number
- 0016
Nova Scotia Health Authority. QEII. Cardiology.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 1496
- Available Online
- View Pamphlet
Ticagrelor is a medicine used along with low dose Aspirin to reduce your risk of having a heart attack. You should not take Ticagrelor if you have or had a current bleeding problem such as bleeding from a stomach ulcer or if you have severe liver disease. Instructions for how to take and store this medicine as well as drug interactions and foods to avoid are discussed. Missed dose instructions are given. This pamphlet also describes warnings and possible side effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Cardiology
- Alternate Title
- Brilinta
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Platelet Aggregation Inhibitors - therapeutic use
- Adenosine - therapeutic use
- Cardiovascular Diseases - prevention & control
- Myocardial Infarction - prevention & control
- Pulmonary Embolism - prevention & control
- Subjects (LCSH)
- Adenosine
- Anticoagulants (Medicine)
- Cardiovascular system--Diseases--Prevention
- Myocardial infarction--Prevention
- Abstract
- Ticagrelor is a medicine used along with low dose Aspirin to reduce your risk of having a heart attack. You should not take Ticagrelor if you have or had a current bleeding problem such as bleeding from a stomach ulcer or if you have severe liver disease. Instructions for how to take and store this medicine as well as drug interactions and foods to avoid are discussed. Missed dose instructions are given. This pamphlet also describes warnings and possible side effects.
- Responsibility
- Prepared by: Cardiology
- Pamphlet Number
- 1496
Warfarine sodique
https://libcat.nshealth.ca/en/permalink/chpams36661
Nova Scotia Health Authority. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 2063
- Available Online
- View Pamphlet
Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également f…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Services
- Alternate Title
- Coumadin
- Warfarin sodium
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- French
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Warfarin
- Anticoagulants
- Subjects (LCSH)
- Warfarin
- Anticoagulants (Medicine)
- Abstract
- Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également fournies sur la façon de prendre le médicament, les doses manquées, les analyses sanguines RIN (ou INR), les interactions médicamenteuses et alimentaires, les effets secondaires et les mesures de sécurité. Vous y trouverez aussi des numéros où appeler si vous avez des questions.
- This is a French translation of the English pamphlet 0373 “Warfarin Sodium". This pamphlet gives specific directions if you are a patient on warfarin and you are undergoing treatment for at least one of the following conditions: atrial fibrillation (irregular heartbeat), prosthetic (artificial) heart valve, venous thrombosis (blood clot in a deep vein) or pulmonary embolism (artery in the lung blocked by a blood clot), myocardial infarction (heart attack), or another related condition. Directions about how to take this medication, missed doses, INR blood tests, drug and food interactions, side effects, and safety precautions are provided. Contact numbers are also given if you have questions.
- Responsibility
- Prepared by: Pharmacy Services ; Revised by: Hematology Services, QEII
- Pamphlet Number
- 2063
